Program Overview

The NewYork-Presbyterian Columbia & Weill Cornell 2025 Breast Cancer Management CME will review state of the art practices in breast cancer screening, highlighting the use of MRI and EUS.  Other topics will include local therapies and the latest advances in systemic therapies as well as a review of the SOUND and INSEMA trials.  The format will consist of lectures, panel discussion, a mock tumor board, where our internationally recognized faculty will present and review complex cases.  

Learning Objectives

1.  Discuss findings in SOUND and INSEMA trials

2.  Describe new updates in breast cancer screening and genetic testing

3.  Discuss new advances in systemic therapies

Target Audience

This program has been designed for primary care physicians, internists, gynecologists, general surgeons, medical oncologists, radiation oncologists, surgical oncologists, radiologists, nurses and other clinicians involved in the management and treatment of patients with breast cancer.  

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Physicians

Amedco LLC designates this live activity for a maximum of 4.00 AMA PRA Category 1 Credits for physicians.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Nurses

Amedco LLC designates this activity for a maximum of 4.00 ANCC contact hours.